Falling gas and used car prices ease inflation. The Department of Labor reported that U.S. consumer prices declined slightly in March for the first time since 2020. The…
Read MorePrescription Drugs
Vice President Celebrates His Mother’s Ten Year Sobriety
He held a private ceremony at the White House and presented her with a challenge coin from President Trump. Vice President JD Vance celebrated with his mother Beverly…
Read More
FDA Approves First Treatment for Rare Disease
Ctexli offers hope for patients with a previously untreated metabolic disorder, Cerebrotendinous Xanthomatosis. The U.S. Food and Drug Administration (FDA) has approved Ctexli (chenodiol) as the first treatment…
Read More
President Trump’s Administration Frees American Teacher
Marc Fogel, who been convicted in Russia for medical marijuana possession, was swapped for a Russian money launderer. President Donald Trump’s Envoy to the Middle East, Steve Witkoff,…
Read More
Federal Court Rules in Favor of Generic Drug Competition in Patent Case
The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read More
Medicare Cost for 64 Drugs Decreases
The savings under the Inflation Reduction Act are anticipated to benefit 853,000 enrollees. Starting January 1, 2025, Medicare enrollees will see reduced coinsurance rates for 64 drugs under…
Read MoreJustice Department Sues CVS Over Prescription Metric Boosting
The department claims the practice contributed to the rise in opioid-related deaths. The Department of Justice (DOJ) sued CVS Health last week, alleging that the company knowingly filled…
Read More
FDA Approves Medication for Rare Adrenal Gland Disorder
Crenessity reduces glucocorticoid dependency and improves hormone control for classic CAH. The FDA has recently approved Crenessity (crinecerfont) for use alongside glucocorticoids in treating adults and children aged…
Read More
FDA Moves to Eliminate Oral Phenylephrine from OTC Nasal Decongestants
Review finds oral phenylephrine ineffective, leading to a proposal for market removal. The U.S. Food and Drug Administration (FDA) recently proposed removing oral phenylephrine from over-the-counter (OTC) products…
Read More
FDA Approves New Hemophilia Treatment Hympavzi
Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…
Read More